The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S. bladder cancer patient registry at the 2025 American Society of Clinical ...

Tommy was diagnosed with bladder cancer just before his 60th birthday. Now, thanks to a Cancer Research UK trial, he’s enjoying playing ...

Researchers led by the University of Ulsan College of Medicine, Korea, have checked the performance of a noninvasive urinary ...

The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S.

The bladder cancer market is poised for transformative growth between 2025 and 2035, driven by rising global incidence rates, ...

Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...

ALA-guided fluorescence cystoscopy is already widely used, and in March 2005 HAL was approved in Europe for the diagnosis of bladder cancer. The approval process continues in the US. Technical ...

Among patients with suspected MIBC, the incorporation of mpMRI for initial staging prior to transurethral resection of ...

Bladder cancer has a cure rate of over 90% when detected ... However, existing urine test kits have low sensitivity, and cystoscopy, which involves inserting a catheter into the urethra for ...

Bladder cancer has a cure rate of over 90% when detected ... However, existing urine test kits have low sensitivity, and cystoscopy, which involves inserting a catheter into the urethra for ...

Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 128.6 million in the fourth quarter of 2024 (Q4 2023: NOK ...